menu
    • menu

    Company profile for Verve Therapeutics

    NEW Drugs in Dev: 4
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide. Verve brings together two of the biggest breakthroughs in 21st century biomedicine — human genetic analysis and gene editing — to realize a new future, one of longevity and vitality for tens of...
    Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide. Verve brings together two of the biggest breakthroughs in 21st century biomedicine — human genetic analysis and gene editing — to realize a new future, one of longevity and vitality for tens of millions of people worldwide at risk of coronary artery disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Verve TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    215 First Street, Suite 440 Cambridge, MA 02142
    Telephone
    Telephone
    (617) 603-0070
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vervetx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/verve-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/VerveTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lilly's VERVE-102 Cuts PCSK9 by 88% & LDL-C by 62% in Single Dose
    Lilly's VERVE-102 Cuts PCSK9 by 88% & LDL-C by 62% in Single Dose

    25 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/a-single-dose-of-lillys-pcsk9-base-editor-verve-102-reduced-pcsk9-by-up-to-88-and-ldl-c-by-up-to-62-with-durable-effects-supporting-its-potential-as-a-one-time-treatment-for-hypercholesterolemia-302780172.html

    PR NEWSWIRE
    25 May 2026
    Share Share
    Lilly Completes Acquisition of Verve Therapeutics
    Lilly Completes Acquisition of Verve Therapeutics

    25 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-completes-acquisition-of-verve-therapeutics-to-advance-one-time-treatments-for-people-with-high-cardiovascular-risk-302513948.html

    PR NEWSWIRE
    25 Jul 2025
    Share Share
    Lilly and Verve Confirm End of Verve Tender Offer
    Lilly and Verve Confirm End of Verve Tender Offer

    24 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-and-verve-announce-expiration-of-verve-tender-offer-302513075.html

    PR NEWSWIRE
    24 Jul 2025
    Share Share
    Eli Lilly nears $1.3 Billion Deal for Verve Therapeutics
    Eli Lilly nears $1.3 Billion Deal for Verve Therapeutics

    17 Jun 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-nears-13-billion-deal-gene-editing-biotech-verve-therapeutics-ft-2025-06-16/

    REUTERS
    17 Jun 2025
    Share Share
    Verve Posts Clean Pcsk9 Editor Profile, Teeing Up Lilly Decision
    Verve Posts Clean Pcsk9 Editor Profile, Teeing Up Lilly Decision

    14 Apr 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/verves-second-swing-pcsk9-editing-yields-clean-safety-profile-teeing-lilly-opt-decision

    FIERCE BIOTECH
    14 Apr 2025
    Share Share
    Vertex axes Verve gene editing pact amid shift in R&D priorities
    Vertex axes Verve gene editing pact amid shift in R&D priorities

    28 Feb 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/vertex-axes-verve-gene-editing-pact-amid-shift-rd-priorities

    FIERCE BIOTECH
    28 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search